The potential toxicity associated with glucocorticoids requires care and vigilance.
The American College of Rheumatology developed clinical guidance for the use of COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases.
Patients have identified fatigue as one of the most important disease outcomes in rheumatoid arthritis.
In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.
This narrative review aims at elucidating the association between ILD and RA in older individuals.
Rheumatologists and rheumatology providers across the United States have expressed their support and provided guidance for patients in light of Rheumatoid Arthritis Awareness Day this year.
Osteoporosis can affect people of any age, race, and sex. Recognition of the misconceptions surrounding the condition may help patients understand its complexity.
A deeper insight into the association between treatment with biologic disease-modifying antirheumatic drugs in rheumatic diseases and risk for type 2 diabetes.
Patients with rheumatoid arthritis are at increased risk for ischemic and non-ischemic heart disease.
There are still significant unmet needs among these patients, many of whom continue to report significant residual symptoms, including pain, fatigue, and functional disability, according to a systematic review.